whitepaper
Scientific briefing: Formulation-Monodisperse CR quetiapine microspheres
Adare’s Optimµm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.
List view / Grid view
ADARE Pharma Solutions
whitepaper
Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
Using a proprietary Stratµm TM technology, we have created 50 µm capsules with an aqueous core and thin PLA shell.
whitepaper
Scientific briefing: Dissolution development Parvulet technology with oral tablets
Parvulet™ Technology is a patented oral dosage form capable of being dispensed to patients in tablet or powders, and converted into a semi-solid with water.
whitepaper
Article: Improved drug delivery with precision particle fabrication
Improved drug delivery with precision particle fabrication-enabling precise control over particle structure.
whitepaper
Whitepaper: Expanding solutions for challenging APIs
Expanding solutions for challenging APIs through the coacervation process.
whitepaper
Case study: MMTS Mini tabs child-friendly dosing
MMTS Mini tabs delivers child-friendly, broad-range dosing for toddlers.
whitepaper
Case study: Microcaps exceeds stringent requirements
Microcaps exceeds stringent requirements beyond taste masking.
whitepaper
Case study: Finding impurities and controlling formations at release
Case study example regarding finding impurities and controlling formations at release.
whitepaper
Interactive PDF: ADARE
Overview of Adare Pharma Solutions- a leading global CDMO with innovative oral dose technology platforms.
